Outfitter Financial’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,065
| Closed | -$246K | – | 81 |
|
|
2024
Q4 | $246K | Sell |
13,065
-5,720
| -30% | -$108K | 0.2% | 80 |
|
|
2024
Q3 | $283K | Sell |
18,785
-1,405
| -7% | -$21.1K | 0.23% | 76 |
|
|
2024
Q2 | $578K | Buy |
20,190
+1,095
| +6% | +$31.3K | 0.48% | 65 |
|
|
2024
Q1 | $558K | Buy |
19,095
+65
| +0.3% | +$1.9K | 0.46% | 65 |
|
|
2023
Q4 | $642K | Sell |
19,030
-13,275
| -41% | -$448K | 0.56% | 62 |
|
|
2023
Q3 | $991K | Buy |
32,305
+110
| +0.3% | +$3.38K | 0.93% | 44 |
|
|
2023
Q2 | $1.29M | Buy |
32,195
+795
| +3% | +$31.9K | 1.15% | 40 |
|
|
2023
Q1 | $1.28M | Buy |
31,400
+5,540
| +21% | +$226K | 1.15% | 40 |
|
|
2022
Q4 | $998K | Buy |
25,860
+440
| +2% | +$17K | 0.91% | 48 |
|
|
2022
Q3 | $1.35M | Buy |
25,420
+855
| +3% | +$45.5K | 1.32% | 29 |
|
|
2022
Q2 | $1.43M | Sell |
24,565
-125
| -0.5% | -$7.29K | 1.3% | 29 |
|
|
2022
Q1 | $1.88M | Hold |
24,690
| – | – | 1.44% | 26 |
|
|
2021
Q4 | $1.49M | Buy |
24,690
+1,000
| +4% | +$60.2K | 1.09% | 36 |
|
|
2021
Q3 | $1.33M | Buy |
23,690
+240
| +1% | +$13.4K | 1.04% | 40 |
|
|
2021
Q2 | $1.42M | Sell |
23,450
-445
| -2% | -$27K | 1.09% | 38 |
|
|
2021
Q1 | $1.68M | Sell |
23,895
-1,345
| -5% | -$94.3K | 1.38% | 26 |
|
|
2020
Q4 | $1.51M | Buy |
+25,240
| New | +$1.51M | 1.46% | 26 |
|